Page last updated: 2024-10-19

niacinamide and Diffuse Parenchymal Lung Disease

niacinamide has been researched along with Diffuse Parenchymal Lung Disease in 2 studies

nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.

Research Excerpts

ExcerptRelevanceReference
"A 74-year-old man was diagnosed with hepatocellular carcinoma(HCC; S4/8)and underwent anterior segment resection of the liver in 2015."5.43[Treatment Experience with Sorafenib for Lung Metastases of Hepatocellular Carcinoma Complicated with Interstitial Pneumonia]. ( Hasegawa, J; Hirota, M; Kameda, C; Kawabata, R; Koga, C; Matsumura, T; Murakami, M; Noura, S; Shimizu, J; Shuto, T; Yasuyama, A; Yoshikawa, M, 2016)
"A 74-year-old man was diagnosed with hepatocellular carcinoma(HCC; S4/8)and underwent anterior segment resection of the liver in 2015."1.43[Treatment Experience with Sorafenib for Lung Metastases of Hepatocellular Carcinoma Complicated with Interstitial Pneumonia]. ( Hasegawa, J; Hirota, M; Kameda, C; Kawabata, R; Koga, C; Matsumura, T; Murakami, M; Noura, S; Shimizu, J; Shuto, T; Yasuyama, A; Yoshikawa, M, 2016)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shuto, T1
Murakami, M1
Shimizu, J1
Koga, C1
Yasuyama, A1
Matsumura, T1
Kameda, C1
Kawabata, R1
Hirota, M1
Yoshikawa, M1
Noura, S1
Hasegawa, J1
Ide, S1
Soda, H1
Hakariya, T1
Takemoto, S1
Ishimoto, H1
Tomari, S1
Sawai, T1
Nagashima, S1
Furukawa, M1
Nakamura, Y1
Kohno, S1

Other Studies

2 other studies available for niacinamide and Diffuse Parenchymal Lung Disease

ArticleYear
[Treatment Experience with Sorafenib for Lung Metastases of Hepatocellular Carcinoma Complicated with Interstitial Pneumonia].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2016, Volume: 43, Issue:12

    Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Lung Diseases, Inte

2016
Interstitial pneumonia probably associated with sorafenib treatment: An alert of an adverse event.
    Lung cancer (Amsterdam, Netherlands), 2010, Volume: 67, Issue:2

    Topics: Antineoplastic Agents; Asian People; Benzenesulfonates; Bone Neoplasms; Carcinoma, Renal Cell; Human

2010